
A synthetic growth-hormone-releasing hormone (GHRH) analogue studied in research into GHRH-receptor signalling, the GH axis and metabolic pathways in experimental models.
HPLC ≥99% research peptides · Southampton since 2019 · next-day mainland
CJC-1295 (No DAC) · CAS 863288-34-0 · GH Axis
Solent Peptides supplies CJC-1295 (No DAC) 5 mg as a defined research chemical from Southampton. Also listed as Modified GRF 1-29, Mod GRF 1-29. A 29-residue GHRH analogue (modified GRF 1-29) without Drug Affinity Complex, studied in GH-axis receptor models. Live UK price £23.36 (typical list £25.95). HPLC ≥99% at batch release. Laboratory use only — not a licensed medicine.
Solent Peptides supplies CJC-1295 (No DAC) 5 mg from Southampton as an HPLC ≥99% research chemical. CAS 863288-34-0. Live UK price £23.36. Lot on the vial. Next-working-day mainland dispatch. Laboratory use only — not a licensed medicine. https://www.solentpeptides.co.uk/product/cjc-1295-no-dac
| Amount | Live UK price | Typical list | Product |
|---|---|---|---|
| 2 mg | £11.66 | £12.95 | CJC-1295 (No DAC) 2 mg |
| 5 mg | £23.36 | £25.95 | CJC-1295 (No DAC) 5 mg |
| 10 mg | £35.99 | £39.99 | CJC-1295 No DAC 10 mg |
A 29-residue GHRH analogue (modified GRF 1-29) without Drug Affinity Complex, studied in GH-axis receptor models. Identity is CAS 863288-34-0. CJC-1295 (No DAC) is a GH-axis research ligand (GHRH analogue, secretagogue or related protein). It is not a steroid, not recombinant hGH, and not a licensed medicine.
Catalogue sizes for CJC-1295 (No DAC): 2 mg, 5 mg, 10 mg. This page is the 5 mg SKU at £23.36. Each size has its own product URL. Typical UK list is shown where we have a compare-at figure. Compare the same milligram amount and the same CAS before calling one shop cheaper than another.
CJC-1295 (No DAC) lots are released at ≥ 99% (HPLC) with identity confirmation against CAS 863288-34-0. The lot number is on the vial. A paper certificate is not currently enclosed in every box. For a paid order, email sales@solentpeptides.co.uk with the order ID or the lot. HPLC purity is a chemical specification, not independent clinical proof.
Orders packed on a weekday before 14:00, payment cleared, typically reach most mainland UK addresses the next working day. No public walk-in counter. Guest checkout. sales@solentpeptides.co.uk · WhatsApp 07380 370380.
A 29-residue GHRH analogue (modified GRF 1-29) without Drug Affinity Complex, studied in GH-axis receptor models. Public identifier CAS 863288-34-0. Also catalogued as Modified GRF 1-29, Mod GRF 1-29. Solent Peptides supplies CJC-1295 (No DAC) (5 mg) as a defined lyophilised solid for non-clinical laboratory work, dispatched from Southampton after HPLC identity and purity checks. It is not a medicine, not a food, and not a cosmetic.
CJC-1295 (No DAC) is a GH-axis research ligand (GHRH analogue, secretagogue or related protein). It is not a steroid, not hGH, and not a licensed medicine. Typical use is receptor-binding, cell-culture or analytical method development.
Solent Peptides lists CJC-1295 (No DAC) 5 mg for laboratory research from Southampton at £23.36. HPLC ≥99%. Research use only.
2 mg £11.66; 5 mg £23.36; 10 mg £35.99. Live catalogue; promotions can change.
Yes. ≥ 99% (HPLC) at batch release, identity against CAS 863288-34-0. Lot on the vial.
No. CJC-1295 (No DAC) 5 mg is sold as a research chemical, not as a licensed medicine, and not for human or veterinary use.
Not currently as a printed insert in every carton. Email the order ID or vial lot for batch confirmation.

A synthetic growth-hormone-releasing hormone (GHRH) analogue studied in research into GHRH-receptor signalling, the GH axis and metabolic pathways in experimental models.

A synthetic analogue of the first 29 amino acids of growth-hormone-releasing hormone (GHRH 1–29), studied in research into GHRH-receptor signalling and the GH axis in experimental models.

A synthetic growth-hormone-releasing hexapeptide studied in research into ghrelin and GHS-receptor signalling within GH-axis models.

A selective pentapeptide growth-hormone secretagogue-receptor agonist studied in GH-axis signalling models.